GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alimera Sciences Inc (STU:ASZ1) » Definitions » E10

Alimera Sciences (STU:ASZ1) E10 : €-4.36 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Alimera Sciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alimera Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-4.36 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 14.70% per year. During the past 5 years, the average E10 Growth Rate was 30.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Alimera Sciences was 59.60% per year. The lowest was 5.50% per year. And the median was 49.50% per year.

As of today (2024-05-21), Alimera Sciences's current stock price is €2.865. Alimera Sciences's E10 for the quarter that ended in Mar. 2024 was €-4.36. Alimera Sciences's Shiller PE Ratio of today is .


Alimera Sciences E10 Historical Data

The historical data trend for Alimera Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alimera Sciences E10 Chart

Alimera Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.91 -7.87 -7.20 -7.13 -4.65

Alimera Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.06 -5.66 -6.19 -4.65 -4.36

Competitive Comparison of Alimera Sciences's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Alimera Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alimera Sciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alimera Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alimera Sciences's Shiller PE Ratio falls into.



Alimera Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alimera Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.11/131.7762*131.7762
=-0.110

Current CPI (Mar. 2024) = 131.7762.

Alimera Sciences Quarterly Data

per share eps CPI Adj_EPS
201406 -1.766 100.560 -2.314
201409 -1.979 100.428 -2.597
201412 -2.798 99.070 -3.722
201503 -3.049 99.621 -4.033
201506 -2.539 100.684 -3.323
201509 -0.401 100.392 -0.526
201512 -3.305 99.792 -4.364
201603 -3.367 100.470 -4.416
201606 -2.002 101.688 -2.594
201609 -2.138 101.861 -2.766
201612 -1.280 101.863 -1.656
201703 -1.402 102.862 -1.796
201706 -0.534 103.349 -0.681
201709 -1.007 104.136 -1.274
201712 -1.267 104.011 -1.605
201803 -1.338 105.290 -1.675
201806 -0.770 106.317 -0.954
201809 5.013 106.507 6.202
201812 -0.264 105.998 -0.328
201903 -0.522 107.251 -0.641
201906 -0.938 108.070 -1.144
201909 -0.599 108.329 -0.729
201912 0.072 108.420 0.088
202003 -0.217 108.902 -0.263
202006 -0.453 108.767 -0.549
202009 -0.102 109.815 -0.122
202012 -0.148 109.897 -0.177
202103 -0.529 111.754 -0.624
202106 0.855 114.631 0.983
202109 -0.510 115.734 -0.581
202112 -0.522 117.630 -0.585
202203 -0.772 121.301 -0.839
202206 -0.426 125.017 -0.449
202209 -0.758 125.227 -0.798
202212 -0.510 125.222 -0.537
202303 -0.663 127.348 -0.686
202306 -1.218 128.729 -1.247
202309 -0.056 129.860 -0.057
202312 -0.066 129.419 -0.067
202403 -0.110 131.776 -0.110

Add all the adjusted EPS together and divide 10 will get our e10.


Alimera Sciences  (STU:ASZ1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alimera Sciences E10 Related Terms

Thank you for viewing the detailed overview of Alimera Sciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Alimera Sciences (STU:ASZ1) Business Description

Traded in Other Exchanges
Address
6310 Town Square, Suite 400, Alpharetta, GA, USA, 30005
Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. The company commercializes ILUVIEN in the U.S., Europe, China and the Middle East.

Alimera Sciences (STU:ASZ1) Headlines

No Headlines